private:prosettabiosciences
|
128943
|
May 31st, 2019 12:00AM
|
Prosetta Biosciences Inc
|
332
|
36.00
|
Open
|
Biotechnology
|
May 31st, 2019 03:39AM
|
May 31st, 2019 03:39AM
|
Prosetta Biosciences, Inc. is a 12-year old biotechnology company focused on developing novel small-molecule antiviral therapeutics based on over 25 years of basic research on the Cell-Free Protein Synthesizing Systems (CFPSS).
Our CFPSS drug discovery platform allows for identification of small molecule drugs which may be missed with traditional pharma screening methods.
Prosetta has successfully produced highly potent compounds which disrupt or alter the key protein-protein interactions involved with the assembly of viral capsids and display activity against multiple strains of many viral families.
|
Open
|
|
Open
|
Prosetta Biosciences Inc, 670 5th Street
|
San Francisco
|
California
|
US
|
94107
|
|
Prosetta Biosciences
|
|
Pharmaceuticals & Biotechnology
|
private:prosettabiosciences
|
128943
|
Mar 19th, 2018 12:00AM
|
Prosetta Biosciences Inc
|
267
|
44.00
|
Open
|
Biotechnology
|
Mar 18th, 2018 08:12PM
|
Mar 18th, 2018 08:12PM
|
|
Open
|
|
|
|
|
|
|
|
|
Prosetta Biosciences
|
|
Pharmaceuticals & Biotechnology
|
private:prosettabiosciences
|
128943
|
Feb 17th, 2018 12:00AM
|
Prosetta Biosciences Inc
|
253
|
45.00
|
Open
|
Biotechnology
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Prosetta Biosciences, Inc. is a 12-year old biotechnology company focused on developing novel small-molecule antiviral therapeutics based on over 25 years of basic research on the Cell-Free Protein Synthesizing Systems (CFPSS).
Our CFPSS drug discovery platform allows for identification of small molecule drugs which may be missed with traditional pharma screening methods.
Prosetta has successfully produced highly potent compounds which disrupt or alter the key protein-protein interactions involved with the assembly of viral capsids and display activity against multiple strains of many viral families.
|
|
|
|
|
|
|
|
|
|
Prosetta Biosciences
|
|
Pharmaceuticals & Biotechnology
|
private:prosettabiosciences
|
128943
|
Feb 16th, 2018 12:00AM
|
Prosetta Biosciences Inc
|
253
|
45.00
|
Open
|
Biotechnology
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Prosetta Biosciences, Inc. is a 12-year old biotechnology company focused on developing novel small-molecule antiviral therapeutics based on over 25 years of basic research on the Cell-Free Protein Synthesizing Systems (CFPSS).
Our CFPSS drug discovery platform allows for identification of small molecule drugs which may be missed with traditional pharma screening methods.
Prosetta has successfully produced highly potent compounds which disrupt or alter the key protein-protein interactions involved with the assembly of viral capsids and display activity against multiple strains of many viral families.
|
|
|
|
|
|
|
|
|
|
Prosetta Biosciences
|
|
Pharmaceuticals & Biotechnology
|
private:prosettabiosciences
|
128943
|
Feb 15th, 2018 12:00AM
|
Prosetta Biosciences Inc
|
253
|
45.00
|
Open
|
Biotechnology
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Prosetta Biosciences, Inc. is a 12-year old biotechnology company focused on developing novel small-molecule antiviral therapeutics based on over 25 years of basic research on the Cell-Free Protein Synthesizing Systems (CFPSS).
Our CFPSS drug discovery platform allows for identification of small molecule drugs which may be missed with traditional pharma screening methods.
Prosetta has successfully produced highly potent compounds which disrupt or alter the key protein-protein interactions involved with the assembly of viral capsids and display activity against multiple strains of many viral families.
|
|
|
|
|
|
|
|
|
|
Prosetta Biosciences
|
|
Pharmaceuticals & Biotechnology
|
private:prosettabiosciences
|
128943
|
Feb 14th, 2018 12:00AM
|
Prosetta Biosciences Inc
|
253
|
45.00
|
Open
|
Biotechnology
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Prosetta Biosciences, Inc. is a 12-year old biotechnology company focused on developing novel small-molecule antiviral therapeutics based on over 25 years of basic research on the Cell-Free Protein Synthesizing Systems (CFPSS).
Our CFPSS drug discovery platform allows for identification of small molecule drugs which may be missed with traditional pharma screening methods.
Prosetta has successfully produced highly potent compounds which disrupt or alter the key protein-protein interactions involved with the assembly of viral capsids and display activity against multiple strains of many viral families.
|
|
|
|
|
|
|
|
|
|
Prosetta Biosciences
|
|
Pharmaceuticals & Biotechnology
|
private:prosettabiosciences
|
128943
|
Feb 13th, 2018 12:00AM
|
Prosetta Biosciences Inc
|
253
|
45.00
|
Open
|
Biotechnology
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
Prosetta Biosciences, Inc. is a 12-year old biotechnology company focused on developing novel small-molecule antiviral therapeutics based on over 25 years of basic research on the Cell-Free Protein Synthesizing Systems (CFPSS).
Our CFPSS drug discovery platform allows for identification of small molecule drugs which may be missed with traditional pharma screening methods.
Prosetta has successfully produced highly potent compounds which disrupt or alter the key protein-protein interactions involved with the assembly of viral capsids and display activity against multiple strains of many viral families.
|
|
|
|
|
|
|
|
|
|
Prosetta Biosciences
|
|
Pharmaceuticals & Biotechnology
|
private:prosettabiosciences
|
128943
|
Feb 12th, 2018 12:00AM
|
Prosetta Biosciences Inc
|
253
|
45.00
|
Open
|
Biotechnology
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
Prosetta Biosciences, Inc. is a 12-year old biotechnology company focused on developing novel small-molecule antiviral therapeutics based on over 25 years of basic research on the Cell-Free Protein Synthesizing Systems (CFPSS).
Our CFPSS drug discovery platform allows for identification of small molecule drugs which may be missed with traditional pharma screening methods.
Prosetta has successfully produced highly potent compounds which disrupt or alter the key protein-protein interactions involved with the assembly of viral capsids and display activity against multiple strains of many viral families.
|
|
|
|
|
|
|
|
|
|
Prosetta Biosciences
|
|
Pharmaceuticals & Biotechnology
|
private:prosettabiosciences
|
128943
|
Feb 11th, 2018 12:00AM
|
Prosetta Biosciences Inc
|
253
|
45.00
|
Open
|
Biotechnology
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
Prosetta Biosciences, Inc. is a 12-year old biotechnology company focused on developing novel small-molecule antiviral therapeutics based on over 25 years of basic research on the Cell-Free Protein Synthesizing Systems (CFPSS).
Our CFPSS drug discovery platform allows for identification of small molecule drugs which may be missed with traditional pharma screening methods.
Prosetta has successfully produced highly potent compounds which disrupt or alter the key protein-protein interactions involved with the assembly of viral capsids and display activity against multiple strains of many viral families.
|
|
|
|
|
|
|
|
|
|
Prosetta Biosciences
|
|
Pharmaceuticals & Biotechnology
|
private:prosettabiosciences
|
128943
|
Feb 10th, 2018 12:00AM
|
Prosetta Biosciences Inc
|
253
|
45.00
|
Open
|
Biotechnology
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
Prosetta Biosciences, Inc. is a 12-year old biotechnology company focused on developing novel small-molecule antiviral therapeutics based on over 25 years of basic research on the Cell-Free Protein Synthesizing Systems (CFPSS).
Our CFPSS drug discovery platform allows for identification of small molecule drugs which may be missed with traditional pharma screening methods.
Prosetta has successfully produced highly potent compounds which disrupt or alter the key protein-protein interactions involved with the assembly of viral capsids and display activity against multiple strains of many viral families.
|
|
|
|
|
|
|
|
|
|
Prosetta Biosciences
|
|
Pharmaceuticals & Biotechnology
|